Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

Journal of Experimental Medicine

Volumn 207, Issue 2, 2010, Pages 429-442

  Schilte, Clémentine ^a,b   Couderc, Thérèse ^a,b   Chretien, Fabrice ^a,b   Sourisseau, Marion ^a,c   Gangneux, Nicolas ^a,b   Guivel Benhassine, Florence ^a,c   Kraxner, Anton ^a,b   Tschopp, Jürg ^d   Higgs, Stephen ^e   Michault, Alain ^f   Arenzana Seisdedos, Fernando ^a,c   Colonna, Marco ^g   Peduto, Lucie ^a   Schwartz, Olivier ^a,c   Lecuit, Marc ^a,b,h,i   Albert, Matthew L ^a,b,i  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f Groupe Hospitalier Sud Reunion   (France)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; INTERFERON; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; VIRUS RNA; ALPHA BETA INTERFERON RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTICLE; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; FEVER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTERFERON PRODUCTION; MOUSE; MYALGIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RASH; RNA VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; ALPHAVIRUS INFECTION; ANIMAL; BLOOD; BLOOD CELL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALPHAVIRUS INFECTIONS; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOOD CELLS; CHIKUNGUNYA VIRUS; HUMANS; INTERFERON TYPE I; MICE; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRAL LOAD;

EID: 77149120482     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090851     Document Type: Article

References (58)

1. Alexopoulou, L., A.C. Holt, R. Medzhitov, and R.A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732-738. doi:10.1038/35099560
2. Aricò, E., K.A. Robertson, F. Belardelli, M. Ferrantini, and A.A. Nash. 2004. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection. Vaccine. 22:1433-1440. doi:10.1016/j. vaccine.2003.10.015
3. Barry, G., L. Breakwell, R. Fragkoudis, G. Attarzadeh-Yazdi, J. Rodriguez-Andres, A. Kohl, and J.K. Fazakerley. 2009. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J. Gen. Virol. 90:1382-1391. doi:10.1099/vir.0.007336-0
4. Bender, A., M. Sapp, G. Schuler, R.M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J. Immunol. Methods. 196:121-135. doi:10.1016/0022-1759(96)00079-8
5. Bieback, K., E. Lien, I.M. Klagge, E. Avota, J. Schneider-Schaulies, W.P. Duprex, H. Wagner, C.J. Kirschning, V. Ter Meulen, and S. Schneider-Schaulies. 2002. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76:8729-8736. doi:10.1128/JVI.76.17.8729- 8736.2002
6. Bodenmann, P., and B. Genton. 2006. Chikungunya: an epidemic in real time. Lancet. 368:258. doi:10.1016/S0140-6736(06)69046-6
7. Borgherini, G., P. Poubeau, F. Staikowsky, M. Lory, N. Le Moullec, J.P. Becquart, C. Wengling, A. Michault, and F. Paganin. 2007. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin. Infect. Dis. 44:1401-1407. doi:10.1086/517537
8. Carey, D.E., R.M. Myers, C.M. DeRanitz, M. Jadhav, and R. Reuben. 1969. The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. Trans. R. Soc. Trop. Med. Hyg. 63:434-445. doi:10.1016/0035-9203(69)90030-3
9. Compton, T., E.A. Kurt-Jones, K.W. Boehme, J. Belko, E. Latz, D.T. Golenbock, and R.W. Finberg. 2003. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:4588-4596. doi:10.1128/JVI.77.8.4588-4596.2003
10. Couderc, T., F. Chrétien, C. Schilte, O. Disson, M. Brigitte, F. Guivel-Benhassine, Y. Touret, G. Barau, N. Cayet, I. Schuffenecker, et al. 2008. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 4:e29. doi:10.1371/journal.ppat.0040029
11. Dalod, M., T. Hamilton, R. Salomon, T.P. Salazar-Mather, S.C. Henry, J.D. Hamilton, and C.A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197:885-898. doi:10.1084/jem.20021522
12. Diebold, S.S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L.E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature. 424:324-328. doi:10.1038/nature01783
13. Diebold, S.S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303:1529-1531. doi:10.1126/science.1093616
14. Fleeton, M.N., N. Contractor, F. Leon, J.D. Wetzel, T.S. Dermody, and B.L. Kelsall. 2004. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200:235-245. doi:10.1084/jem.20041132
15. Fredericksen, B.L., B.C. Keller, J. Fornek, M.G. Katze, and M. Gale Jr. 2008. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82:609-616. doi:10.1128/JVI.01305-07
16. Friedman, R.M. 1964. Role of interferon in Viral interference. Nature. 201:848-849. doi:10.1038/201848a0
17. Gardner, C.L., C.W. Burke, M.Z. Tesfay, P.J. Glass, W.B. Klimstra, and K.D. Ryman. 2008. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J. Virol. 82:10634-10646. doi:10.1128/JVI.01323- 08
18. Gérardin, P., V. Guernier, J. Perrau, A. Fianu, K. Le Roux, P. Grivard, A. Michault, X. de Lamballerie, A. Flahault, and F. Favier. 2008. Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect. Dis. 8:99. doi:10.1186/1471-2334-8-99
19. Greiser-Wilke, I., V. Moenning, O.R. Kaaden, and L.T. Figueiredo. 1989. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. J. Gen. Virol. 70:743-748. doi:10.1099/0022-1317-70-3-743
20. Havenar-Daughton, C., G.A. Kolumam, and K. Murali-Krishna. 2006. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176:3315-3319.
21. Hidmark, A.S., G.M. McInerney, E.K. Nordström, I. Douagi, K.M. Werner, P. Liljeström, and G.B. Karlsson Hedestam. 2005. Early alpha/ beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88. J. Virol. 79:10376-10385. doi:10.1128/JVI.79.16.10376-10385.2005
22. Ichinohe, T., H.K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206:79-87. doi:10.1084/jem.20081667
23. Johansson, C., J.D. Wetzel, J. He, C. Mikacenic, T.S. Dermody, and B.L. Kelsall. 2007. Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J. Exp. Med. 204:1349-1358. doi:10.1084/jem.20061587
24. Johnston, R., and C. Peters. 1996. Alphaviruses. In Virology, 3rd edition. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven, New York. 843-898.
25. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441:101-105. doi:10.1038/nature04734
26. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137. doi:10.1038/ni1303
27. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C.H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 22:643-654. doi:10.1016/j.immuni.2005.04.004
28. Krug, A., A.R. French, W. Barchet, J.A. Fischer, A. Dzionek, J.T. Pingel, M.M. Orihuela, S. Akira, W.M. Yokoyama, and M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 21:107-119. doi:10.1016/j.immuni.2004.06.007
29. Kurt-Jones, E.A., L. Popova, L. Kwinn, L.M. Haynes, L.P. Jones, R.A. Tripp, E.E. Walsh, M.W. Freeman, D.T. Golenbock, L.J. Anderson, and R.W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401. doi:10.1038/80833
30. Landis, H., A. Simon-Jödicke, A. Klöti, C. Di Paolo, J.J. Schnorr, S. Schneider-Schaulies, H.P. Hefti, and J. Pavlovic. 1998. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 72:1516-1522.
31. Laurent, P., K. Le Roux, P. Grivard, G. Bertil, F. Naze, M. Picard, F. Staikowsky, G. Barau, I. Schuffenecker, and A. Michault. 2007. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus. Clin. Chem. 53:1408-1414. doi:10.1373/clinchem.2007.086595
32. Lenschow, D.J., C. Lai, N. Frias-Staheli, N.V. Giannakopoulos, A. Lutz, T. Wolff, A. Osiak, B. Levine, R.E. Schmidt, A. García-Sastre, et al. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA. 104:1371-1376. doi:10.1073/pnas.0607038104
33. MacDonald, G.H., and R.E. Johnston. 2000. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74:914-922. doi:10.1128/JVI.74.2.914-922.2000
34. Mavalankar, D., P. Shastri, and P. Raman. 2007. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect. Dis. 7:306-307. doi:10.1016/S1473-3099(07)70091-9
35. Müller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921. doi:10.1126/science.8009221
36. Muzio, M., J. Ni, P. Feng, and V.M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1612-1615. doi:10.1126/science.278.5343.1612
37. Ng, L.F., A. Chow, Y.J. Sun, D.J. Kwek, P.L. Lim, F. Dimatatac, L.C. Ng, E.E. Ooi, K.H. Choo, Z. Her, et al. 2009. IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One. 4:e4261. doi:10.1371/journal.pone.0004261
38. Rassa, J.C., J.L. Meyers, Y. Zhang, R. Kudaravalli, and S.R. Ross. 2002. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. USA. 99:2281-2286. doi:10.1073/pnas.042355399
39. Rieser, C., G. Böck, H. Klocker, G. Bartsch, and M. Thurnher. 1997. Prostaglandin E2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186:1603-1608. doi:10.1084/jem.186.9.1603
40. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kämpgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods. 196:137-151. doi:10.1016/0022-1759(96)00078-6
41. Ryman, K.D., and W.B. Klimstra. 2008. Host responses to alphavirus infection. Immunol. Rev. 225:27-45. doi:10.1111/j.1600-065X.2008.00670.x
42. Ryman, K.D., K.C. Meier, E.M. Nangle, S.L. Ragsdale, N.L. Korneeva, R.E. Rhoads, M.R. MacDonald, and W.B. Klimstra. 2005. Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells. J. Virol. 79: 1487-1499. doi:10.1128/JVI.79.3.1487-1499.2005
43. Sabbah, A., T.H. Chang, R. Harnack, V. Frohlich, K. Tominaga, P.H. Dube, Y. Xiang, and S. Bose. 2009. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10:1073-1080. doi:10.1038/ni.1782
44. Schmitz, N., M. Kurrer, M.F. Bachmann, and M. Kopf. 2005. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 79:6441-6448. doi:10.1128/JVI.79.10.6441-448.2005
45. Schuffenecker, I., I. Iteman, A. Michault, S. Murri, L. Frangeul, M.C. Vaney, R. Lavenir, N. Pardigon, J.M. Reynes, F. Pettinelli, et al. 2006. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 3:e263. doi:10.1371/journal.pmed.0030263
46. Schulz, O., S.S. Diebold, M. Chen, T.I. Näslund, M.A. Nolte, L. Alexopoulou, Y.T. Azuma, R.A. Flavell, P. Liljeström, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature. 433:887-892. doi:10.1038/nature03326
47. Shabman, R.S., T.E. Morrison, C. Moore, L. White, M.S. Suthar, L. Hueston, N. Rulli, B. Lidbury, J.P. Ting, S. Mahalingam, and M.T. Heise. 2007. Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J. Virol. 81:237-247. doi:10.1128/JVI.01590-06
48. Sheppard, P., W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T.E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68. doi:10.1038/ni873
49. Siegal, F.P., N. Kadowaki, M. Shodell, P.A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y.J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1835-1837. doi:10.1126/science.284.5421.1835
50. Simon, F., H. Tolou, and P. Jeandel. 2006. [The unexpected Chikungunya outbreak]. Rev. Med. Interne. 27:437-441 (The unexpected Chikungunya outbreak). doi:10.1016/j.revmed.2006.03.028
51. Sourisseau, M., C. Schilte, N. Casartelli, C. Trouillet, F. Guivel-Benhassine, D. Rudnicka, N. Sol-Foulon, K. Le Roux, M.C. Prevost, H. Fsihi, et al. 2007. Characterization of reemerging chikungunya virus. PLoS Pathog. 3:e89. doi:10.1371/journal.ppat.0030089
52. Stetson, D.B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity. 25:373-381. doi:10.1016/j.immuni.2006.08.007
53. Strauss, J.H., and E.G. Strauss. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
54. van Pesch, V., H. Lanaya, J.C. Renauld, and T. Michiels. 2004. Characterization of the murine alpha interferon gene family. J. Virol. 78:8219-8228. doi:10.1128/JVI.78.15.8219-8228.2004
55. Vanlandingham, D.L., K. Tsetsarkin, C. Hong, K. Klingler, K.L. McElroy, M.J. Lehane, and S. Higgs. 2005. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect Biochem. Mol. Biol. 35:1162-1170. doi:10.1016/j.ibmb.2005.05.008
56. Wagner, R.R. 1964. Inhibition of interferon biosynthesis by actinomycin D. Nature. 204:49-51. doi:10.1038/204049a0
57. Watson, R. 2007. Europe witnesses first local transmission of chikungunya fever in Italy. BMJ. 335:532-533. doi:10.1136/bmj.39332.708738.DB
58. Wu, S.J., G. Grouard-Vogel, W. Sun, J.R. Mascola, E. Brachtel, R. Putvatana, M.K. Louder, L. Filgueira, M.A. Marovich, H.K. Wong, et al. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820. doi:10.1038/77553